Skip to main content
AAO-HNSF 2024 Annual Meeting & OTO EXPO Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Hamid R. Djalilian, MD

Professor of Otolaryngology, Neurosurgery, and Biomedical Engineering, Director of Division of Neurotology and Skull Base Surgery
University of California, Irvine
Irvine, CA, United States

Dr. Djalilian is the professor of otolaryngology, neurosurgery, and biomedical engineering at the University of California Irvine and director of Otology, Neurotology, and Skull Base Surgery at UC Irvine. In addition to routine conditions of the ear, Dr. Djalilian's areas of expertise include complex ear surgery, hearing loss/tinnitus, balance disorders, facial nerve paralysis, and skull base surgery.
He received his medical degree with honors from the University of Minnesota and completed his Otolaryngology residency at the same institution. He completed his fellowship training at the Minnesota Ear, Head & Neck Clinic and the University of Minnesota. He has published over 300 articles and lectured more than 200 times at national and international meetings. In addition to a busy clinical practice, Dr. Djalilian conducts research in several areas related to device and software development for treating tinnitus, hearing loss, dizziness, ear infections, among others. He has multiple granted and pending patents on medical devices and the treatment of tinnitus, otitis media, and hearing loss. He was the first to develop a combined internet-based cognitive behavioral therapy and sound therapy to allow remote treatment of tinnitus (xtinnitus.com).
He is a member of multiple committees of national organization and has been a thought leader on the role of migraine in ear disorders like dizziness, tinnitus, hearing loss, etc. and is currently the president of the Migraine in Otolaryngology Society. He is the chief advisor to telemedicine clinic (neuromedcare.com) to medically treat patients with dizziness, tinnitus, central (non-pulmonary) long COVID, and migraine remotely. He has developed novel therapies for Meniere’s disease, tinnitus, sudden hearing loss, chronic ear fullness, cholesteatomas, TM perforations, facial nerve disorders, and skullbase tumors and CSF leaks.

Presentation(s):

Email Hamid